|
The following tables compute basic and diluted
earnings per share (in thousands, except per share data):
| |
|
Three Months Ended September 30, 2024 |
|
| |
|
Loss
Numerator |
|
|
Shares Denominator |
|
|
Per-Share Amount |
|
| Net loss |
|
$ |
(2,441 |
) |
|
|
|
|
|
|
|
|
| Less: Preferred stock dividends |
|
|
(319 |
) |
|
|
|
|
|
|
|
|
| Basic and diluted loss per share: |
|
|
|
|
|
|
|
|
|
|
|
|
| Loss available to common stockholders |
|
$ |
(2,760 |
) |
|
|
73,835 |
|
|
$ |
(0.04 |
) |
| |
|
Three Months Ended September 30, 2023 |
|
| |
|
Loss
Numerator |
|
|
Shares Denominator |
|
|
Per-Share Amount |
|
| Net loss |
|
$ |
(3,489 |
) |
|
|
|
|
|
|
|
|
| Less: Preferred stock dividends |
|
|
(319 |
) |
|
|
|
|
|
|
|
|
| Basic and diluted loss per share: |
|
|
|
|
|
|
|
|
|
|
|
|
| Loss available to common stockholders |
|
$ |
(3,808 |
) |
|
|
73,191 |
|
|
$ |
(0.05 |
) |
| |
|
Nine Months Ended September 30, 2024 |
|
| |
|
Loss
Numerator |
|
|
Shares Denominator |
|
|
Per-Share Amount |
|
| Net loss |
|
$ |
(17,272 |
) |
|
|
|
|
|
|
|
|
| Less: Preferred stock dividends |
|
|
(950 |
) |
|
|
|
|
|
|
|
|
| Basic and diluted loss per share: |
|
|
|
|
|
|
|
|
|
|
|
|
| Loss available to common stockholders |
|
$ |
(18,222 |
) |
|
|
73,364 |
|
|
$ |
(0.25 |
) |
| |
|
Nine Months Ended September 30, 2023 |
|
| |
|
Loss
Numerator |
|
|
Shares Denominator |
|
|
Per-Share Amount |
|
| Net loss |
|
$ |
(9,060 |
) |
|
|
|
|
|
|
|
|
| Less: Preferred stock dividends |
|
|
(946 |
) |
|
|
|
|
|
|
|
|
| Basic and diluted loss per share: |
|
|
|
|
|
|
|
|
|
|
|
|
| Loss available to common stockholders |
|
$ |
(10,006 |
) |
|
|
73,464 |
|
|
$ |
(0.14 |
) |
There were an additional aggregate potentially
dilutive weighted-average shares of 981,000 from convertible securities outstanding for the three and nine months ended September 30,
2024 and September 30, 2023. These securities were not considered in calculating diluted net income (loss) per share for the three and
nine months ended September 30, 2024 and the three and nine months ended September 30, 2023, as their effect would have been anti-dilutive.
|